ReutersNovartis solid tumor 'CAR T cell' still holds promise: researcherReuters(Reuters) - A new type of immuno-oncology treatment from Novartis AG proved safe in a tiny study of three types of solid tumors, but the trial included too few patients and used too small a dose of the experimental product to prove effectiveness, according to ...Allergic Reaction -- OverheardWall Street JournalNovartis, a leader in targeted therapies, looking to prime the immune system to ...Boston Globe (subscription)Juno Therapeutics (JUNO) Stock Falls Today on Mediocre Solid Tumor Therapy ...TheStreet.comPuget Sound Business Journal (Seattle) (blog) -Benzinga -FierceBiotechall 10 news articles »
Novartis solid tumor 'CAR T cell' still holds promise: researcher
Rating: 4.5
Diposkan Oleh: Unknown
